ALYGLO
LIVE

Serial Number

90160114

Owner

GC BIOPHARMA CORP.

Attorney

Kwang Yup Chae

First Use Date

Jul 8, 2024

Filing Date

Sep 4, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ALYGLO Trademark

Serial Number: 90160114 • Registration: 7580083

ALYGLO is a trademark filed by GC BIOPHARMA CORP. on September 4, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GC BIOPHARMA CORP.

107, Ihyeon-ro 30beon-gil, Giheung-gu,
Yongin-si, Gyeonggi-do 16924 , KR

Entity Type: 03

Green Cross Corporation (10 trademarks)

Yongin-si, Gyeonggi-do 16924 , KR

Entity Type: 03

Trademark Details

Filing Date

September 4, 2020

Registration Date

November 26, 2024

First Use Anywhere

July 8, 2024

First Use in Commerce

July 8, 2024

Published for Opposition

April 20, 2021

Goods & Services

Blood plasma derivatives for medical purposes, namely, immune globulins including Rh immune globulin; Immunoglobulin reparations, namely, pharmaceutical immunoglobulin preparations for treatment of primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich Syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP); all the foregoing for patient treatment by injection or in liquid form by health professional

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 26, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 26, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 24, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 24, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 24, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 23, 2024 AITU
USE AMENDMENT FILED
Aug 19, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 19, 2024 EISU
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 3, 2024 ASCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 15, 2024 EXRA
SOU EXTENSION 4 GRANTED
Feb 14, 2024 EX4G
SOU EXTENSION 4 FILED
Feb 14, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 30, 2023 EXRA
SOU EXTENSION 3 GRANTED
Aug 28, 2023 EX3G
SOU EXTENSION 3 FILED
Aug 28, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 28, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 24, 2023 EXRA
SOU EXTENSION 2 GRANTED
Feb 22, 2023 EX2G
SOU EXTENSION 2 FILED
Feb 22, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 22, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 4, 2022 EXRA
SOU EXTENSION 1 GRANTED
Aug 2, 2022 EX1G
SOU EXTENSION 1 FILED
Aug 2, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 2, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 24, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 24, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 24, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 24, 2022 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 1, 2022 NOAM
CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Feb 7, 2022 CHPB
ASSIGNED TO PETITION STAFF
Feb 2, 2022 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jan 26, 2022 EPPA
TTAB RELEASE CASE TO TRADEMARKS
Jan 20, 2022 TMBN
OPPOSITION TERMINATED NO. 999999
Jan 20, 2022 OP.T
OPPOSITION DISMISSED NO. 999999
Jan 20, 2022 OP.D
OPPOSITION INSTITUTED NO. 999999
Oct 18, 2021 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
May 6, 2021 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 20, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 20, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 31, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 10, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 10, 2021 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jan 13, 2021 GPRN
PRIORITY ACTION E-MAILED
Jan 13, 2021 GPRA
PRIORITY ACTION WRITTEN
Jan 13, 2021 CPRA
ASSIGNED TO EXAMINER
Jan 12, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 9, 2020 NWOS
NEW APPLICATION ENTERED
Sep 8, 2020 NWAP